医疗耗材行业周报：财报披露密集期，关注创新高值耗材企业业绩表现

Industry Investment Rating - The report maintains an "Overweight" rating for the medical consumables industry [6][17] Core Views - The medical consumables sector rose 0 76% last week, outperforming the CSI 300 by 1 15 percentage points [3][8] - The sector's PE ratio is 31 89X, up 0 28 percentage points from the previous week, while the PB ratio is 2 19X, indicating historically low valuations [4][10] - Domestic high-value consumables companies are increasing R&D investments, with new product approvals expected to accelerate import substitution in areas like cardiac electrophysiology and vascular intervention [6][17] Sector Performance - The medical consumables sector closed at 4840 55 points, up 0 76% last week [3][8] - Top-performing companies include Zhonghong Medical (+16 5%), Sanyou Medical (+7 7%), and Anjie Medical (+6 1%) [9] - Underperforming companies include Jianfan Biotech (-1 6%), Bairun Medical (-2 4%), and Lepu Medical (-2 6%) [9] Company Performance - Jianfan Biotech reported H1 2024 revenue of 1 496 billion yuan, up 47 77% YoY, with net profit of 553 million yuan, up 99 10% YoY [5][13] - Anjie Medical achieved H1 2024 revenue of 264 million yuan, up 28 43% YoY, with net profit of 124 million yuan, up 57 93% YoY [5][14] - Sanxin Medical reported H1 2024 revenue of 686 45 million yuan, up 18% YoY, with net profit of 106 25 million yuan, up 18 74% YoY [5][15] - Zhenghai Biotech's H1 2024 revenue declined 11 80% YoY to 198 02 million yuan, with net profit down 21 68% YoY to 86 03 million yuan [5][12] Investment Recommendations - Focus on innovative interventional and electrophysiological consumables companies with strong product pipelines [6][17] - Pay attention to low-value consumables companies showing positive business development trends in 2024 [6][17]